Skip Navigation

Personalizing neurosurgical treatment through genetic discovery Dr. Bettegowda viewing patient scans on a computer

Led by Dr. Chetan Bettegowda, our lab uses genetic analysis, biomarkers and patient outcome data to identify better ways to diagnose and treat disease. We research a variety of neurological conditions, including central nervous system tumors, trigeminal neuralgia and traumatic brain and spinal injuries.


Learn more about the lab

To learn more about our work, discuss collaboration or connect about joining our team, contact Dr. Jordina Rincon-Torroella


News & Media (Slideshow)


    Our lab is supported by several federal and private grants, including:

    • MRgFUS-enabled Non-Invasive Interrogation of Malignant Glioma via Circulating Tumor
      Source: DNA NINDS R21NS113016-01
    • Tumor Derived DNA in Cerebrospinal Fluid as a Biomarker for Central Nervous System Malignancies
      Source: NCI R37 CA230400-01
    • Translational Molecular Profiling of Oligodendrogliomas
      Source: Burroughs Wellcome Fund Career Award for Medical Scientists
    • Biomarkers for Children With Brain Tumors
      Source: Ian’s Friend’s Foundation
    • PTRON – Primary Tumor Research and Outcome Network
      Source: AOSpine
    • Alpha-1 Andrenergic Receptor Antagonism to Prevent COVID-19 Cytokine Storm Syndrome and Acute Respiratory Distress
      Source: Progressive Learning Inc.
    • Assessment of Safety and Feasibility of Exablate Type 2 Blood
      Source: INSIGHTEC
    • Quantitative Phase IIA Trial of Dichloroacetate for Glioblastoma Multiforme
      Source: NIH/University of Florida R01 FD007271-01
    • MTRON – Metastatic Tumor Research and Outcome Network
      Source: AOSpine
    back to top button